NCT01217047

Brief Summary

This research is being done to study the effect of Functional Electrical Stimulation (FES) cycling on factors in blood and spinal cord in people with spinal cord injury (SCI).

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
11

participants targeted

Target at below P25 for phase_2

Timeline
Completed

Started Oct 2010

Typical duration for phase_2

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 2, 2010

Completed
29 days until next milestone

Study Start

First participant enrolled

October 1, 2010

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 8, 2010

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2013

Completed
7.5 years until next milestone

Results Posted

Study results publicly available

January 27, 2021

Completed
Last Updated

January 27, 2021

Status Verified

January 1, 2021

Enrollment Period

2.8 years

First QC Date

September 2, 2010

Results QC Date

November 13, 2020

Last Update Submit

January 7, 2021

Conditions

Keywords

Spinal cord injuryFunctional electrical stimulationRehabilitationGrowth factorsCytokines

Outcome Measures

Primary Outcomes (2)

  • CSF Brain Derived Neurotrophic Factor (BDNF) Level

    We will quantify levels of BDNF in the cerebrospinal fluid (CSF) using immunohistochemical quantification methods.

    Baseline

  • CSF Brain Derived Neurotrophic Factor (BDNF) Level

    We will quantify levels of BDNF in the cerebrospinal fluid (CSF) using immunohistochemical quantification methods.

    At 3 weeks

Secondary Outcomes (7)

  • Mood Assessment

    3 weeks

  • Spasticity Testing Using the Modified Ashworth Scale (MAS)

    Baseline

  • CSF Growth Factor Quantification

    Baseline

  • Serum Brain Derived Neurotrophic Factor (BDNF) Level

    Baseline

  • Spasticity Testing Using the Modified Ashworth Scale (MAS)

    At 3 weeks

  • +2 more secondary outcomes

Study Arms (4)

Group A

EXPERIMENTAL

For 3 weeks, you will need to come to the ICSCI one (1) time per week during which you will perform FES cycling for 1 hour each.

Device: FES CyclingProcedure: Lumbar punctureBehavioral: Mood assessment

Group B

EXPERIMENTAL

For 3 weeks, you will need to come to the ICSCI three (3) times per week during which you will perform FES cycling for 1 hour each.

Device: FES CyclingProcedure: Lumbar punctureBehavioral: Mood assessment

Group C

EXPERIMENTAL

For 3 weeks, you will need to come to the ICSCI five (5) times per week during which you will perform FES cycling for 1 hour each.

Device: FES CyclingProcedure: Lumbar punctureBehavioral: Mood assessment

Group D

EXPERIMENTAL

For 3 weeks, you will need to come to the ICSCI three (3) times per week during which you will perform cycling without FES for 1 hour each.

Device: Cycling without FESProcedure: Lumbar punctureBehavioral: Mood assessment

Interventions

You will be seated in your own wheelchair in front of the cycle. We will place your legs onto the cycle and secure them with straps. Electrodes (pads that stick to the skin) will be placed on your skin on your legs and buttock. The pads will be connected to a stimulator box through a wire. We will then start the cycle motor and stimulate your leg and buttock muscles with electric current. This will cause your legs to cycle. You will do this for 1 hour.

Also known as: RT300-SL, from Restorative Therapies, INC.
Group AGroup BGroup C

You will be seated in your own wheelchair in front of the cycle. We will place your legs onto the cycle and secure them with straps. The cycle is configured to work without FES. We will then start the cycle motor. This will cause your legs to cycle. You will do this for 1 hour.

Also known as: RT300-SL, from Restorative Therapies, INC.
Group D

The study includes 2 lumbar punctures: one at the beginning of the study and one at the end. During a lumbar puncture a small needle will be inserted into the lower back and a small amount of spinal fluid will be drained (about 1 tablespoon).

Also known as: Spinal tap
Group AGroup BGroup CGroup D
Mood assessmentBEHAVIORAL

If you do not already have an account, you will be signed up with "Mood24/7" (http://www.mood247.com). This is a free service that texts your mobile phone daily asking you to rate your mood on a scale of 1 (low) through 10 (high). We will not monitor your entries during the study but only at the final visit when we will get a printout of the course of your mood during the study. After completion of the study we will assist you in removing us from your Mood24/7 account and we will no longer have access to your mood reports outside of the study period.

Also known as: Mood24/7
Group AGroup BGroup CGroup D

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • History of traumatic spinal cord injury sustained at least 6 months prior
  • Complete spinal cord injury at any level American Spinal Injury Association (ASIA) impairment scale A
  • No use of functional electrical stimulation within 3 months
  • Medically stable, with no recent (1 month or less) inpatient admission for acute medical or surgical issues
  • Legally able to make own health care decisions

You may not qualify if:

  • Cardiovascular disease as defined by previous myocardial infarction, unstable angina, requirement for anti platelet agents, congestive heart failure, or stroke, history of arrhythmia with hemodynamic instability
  • Uncontrolled hypertension (resting systolic blood pressure (BP) \>160mmHg or diastolic BP \>100mmHg consistently)
  • Concurrent lower motor neuron disease such as peripheral neuropathy that would exclude lower extremity electrical excitability
  • Unstable long bone fractures of the lower extremities
  • Subjects who are unwilling to agree to two (2) CSF examinations (lumbar punctures)
  • Presence of cardiac pacemaker and/or defibrillator
  • Presence of cancer
  • History of epileptic seizures
  • Subjects having a Stage 2 or greater sacral decubitus ulcer
  • Women who are pregnant
  • Active drug or alcohol use or dependence

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kennedy Krieger Institute

Baltimore, Maryland, 21205, United States

Location

MeSH Terms

Conditions

Spinal Cord Injuries

Interventions

Spinal Puncture

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and Injuries

Intervention Hierarchy (Ancestors)

BiopsySpecimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisDiagnostic Techniques, NeurologicalPuncturesTherapeuticsSurgical Procedures, OperativeInvestigative Techniques

Results Point of Contact

Title
Daniel Becker, M.D.
Organization
Kennedy Krieger Institute

Study Officials

  • Daniel Becker, M.D.

    Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 2, 2010

First Posted

October 8, 2010

Study Start

October 1, 2010

Primary Completion

August 1, 2013

Study Completion

August 1, 2013

Last Updated

January 27, 2021

Results First Posted

January 27, 2021

Record last verified: 2021-01

Locations